AI-generated summary
The authors describe a protocol for a single-centre, single-armed feasibility study of whole-body photobiomodulation therapy using the NovoTHOR device in adults with chronic pain. The planned intervention is 18 treatments over 6 weeks with 6-month follow-up, and the study will focus on acceptability of trial processes to guide a future randomised trial. No results are reported.
- Participants
- 20
- Who or what was studied
- Adults with a clinician diagnosis of chronic axial pain, polyarthralgia, myofascial pain or widespread pain, recruited by self-referral and clinician referral.
- Limits stated in the abstract
- The study has no placebo or control group and uses a non-probability sample of 20 participants, and it reports a protocol without outcome results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on bmjopen.bmj.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.